Patient relevant endpoints in oncology: current issues in the context of early benefit assessment in Germany

Inna Dabisch (), Jürgen Dethling (), Charalabos-Markos Dintsios (), Melanie Drechsler (), Daniel Kalanovic (), Peter Kaskel (), Frank Langer (), Jörg Ruof (), Thorsten Ruppert () and Daniel Wirth ()

Health Economics Review, 2014, vol. 4, issue 1, 1-8

Abstract: D61; H51; I18. Copyright Dabisch et al.; licensee Springer. 2014

Keywords: AMNOG; German health care reform; Oncology; Endpoints; Progression-free survival; Patient-relevant benefit (search for similar items in EconPapers)
JEL-codes: D61 H51 I18 (search for similar items in EconPapers)
Date: 2014
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (5)

Downloads: (external link)
http://hdl.handle.net/10.1186/2191-1991-4-2 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:hecrev:v:4:y:2014:i:1:p:1-8:10.1186/2191-1991-4-2

Ordering information: This journal article can be ordered from
http://www.springer.com/journal/13561

DOI: 10.1186/2191-1991-4-2

Access Statistics for this article

Health Economics Review is currently edited by J. Matthias Graf von der Schulenburg

More articles in Health Economics Review from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().